BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9221054)

  • 21. Treatment of non-insulin-dependent diabetes mellitus and its complications. A state of the art review.
    Ilarde A; Tuck M
    Drugs Aging; 1994 Jun; 4(6):470-91. PubMed ID: 8075474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of type 2 diabetes mellitus in the elderly: special considerations.
    Rosenstock J
    Drugs Aging; 2001; 18(1):31-44. PubMed ID: 11232737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Role of insulin secretagogues in the treatment of type 2 diabetes].
    Radermecker RP
    Rev Med Liege; 2005; 60(5-6):402-8. PubMed ID: 16035301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in the treatment of type 2 diabetes mellitus.
    Israili ZH
    Am J Ther; 2011; 18(2):117-52. PubMed ID: 19834322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type 2 diabetes mellitus: epidemiology, pathophysiology, unmet needs and therapeutical perspectives.
    Virally M; Blicklé JF; Girard J; Halimi S; Simon D; Guillausseau PJ
    Diabetes Metab; 2007 Sep; 33(4):231-44. PubMed ID: 17703979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Type 2 diabetes mellitus.
    DeFronzo RA; Ferrannini E; Groop L; Henry RR; Herman WH; Holst JJ; Hu FB; Kahn CR; Raz I; Shulman GI; Simonson DC; Testa MA; Weiss R
    Nat Rev Dis Primers; 2015 Jul; 1():15019. PubMed ID: 27189025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunologic and insulin secretion markers in non insulin dependent diabetic patients with secondary failure to oral hypoglycemic drugs].
    Maiz A; Manrique M; Arteaga A; Acosta AM; Andrade L
    Rev Med Chil; 1995 Oct; 123(10):1199-203. PubMed ID: 8733310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The treatment of type II diabetes].
    Curchod B; Chevaux F
    Rev Med Suisse Romande; 1988 Jul; 108(7):559-64. PubMed ID: 3045938
    [No Abstract]   [Full Text] [Related]  

  • 29. [The current aspects of the pharmacological correction of hyperglycemia in patients with non-insulin-dependent diabetes mellitus (type 2)].
    Gorbenko NI
    Eksp Klin Farmakol; 1999; 62(5):71-8. PubMed ID: 10572759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Non-pharmacological therapy of metabolic syndrome].
    Wirth A
    Herz; 1995 Feb; 20(1):56-69. PubMed ID: 7713478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current and Emerging Pharmacotherapies for Weight Management in Prediabetes and Diabetes.
    Lau DC; Teoh H
    Can J Diabetes; 2015 Dec; 39 Suppl 5():S134-41. PubMed ID: 26654857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Weight loss reverses secondary failure of oral hypoglycaemic agents in obese non-insulin-dependent diabetic patients independently of the duration of the disease.
    Pontiroli AE; Calderara A; Pacchioni M; Cassisa C; Pozza G
    Diabete Metab; 1993; 19(1):30-5. PubMed ID: 8504882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The lean patient with type 2 diabetes: characteristics and therapy challenge.
    P B
    Int J Clin Pract Suppl; 2007 Jun; (153):3-9. PubMed ID: 17594388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of Current and Emerging Glucose-Lowering Drugs on Body Weight in Type 2 Diabetes.
    Lau DC; Teoh H
    Can J Diabetes; 2015 Dec; 39 Suppl 5():S148-54. PubMed ID: 26654858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapies for newly-onset diabetic patients].
    Kawamori R
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():525-32. PubMed ID: 15779435
    [No Abstract]   [Full Text] [Related]  

  • 36. Treating non-insulin-dependent diabetes. Oral agents or insulin?
    Shlossberg AH
    Can Fam Physician; 1993 Jan; 39():119-20, 123-6. PubMed ID: 8435549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gycemic control, mealtime glucose excursions, and diabetic complications in type 2 diabetes mellitus.
    Palumbo PJ
    Mayo Clin Proc; 2001 Jun; 76(6):609-18. PubMed ID: 11393500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benefits and risks of transfer from oral agents to insulin in type 2 diabetes mellitus.
    Evans A; Krentz AJ
    Drug Saf; 1999 Jul; 21(1):7-22. PubMed ID: 10433350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Evaluation of insulinosecretion and insulinosensitivity].
    Scheen AJ
    Therapie; 2007; 62(4):311-8. PubMed ID: 17983556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.